ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05321	Inflammatory bowel disease (IBD)	1/1	56/7206	0.00777130169305
ko05140	Leishmaniasis	1/1	75/7206	0.0104079933389
ko05212	Pancreatic cancer	1/1	83/7206	0.0115181792951
ko04917	Prolactin signaling pathway	1/1	87/7206	0.0120732722731
ko04658	Th1 and Th2 cell differentiation	1/1	96/7206	0.0133222314738
ko04620	Toll-like receptor signaling pathway	1/1	100/7206	0.0138773244518
ko04659	Th17 cell differentiation	1/1	106/7206	0.014709963919
ko05162	Measles	1/1	120/7206	0.0166527893423
ko05145	Toxoplasmosis	1/1	126/7206	0.0174854288093
ko04630	Jak-STAT signaling pathway	1/1	132/7206	0.0183180682765
ko04380	Osteoclast differentiation	1/1	134/7206	0.0185956147655
ko04933	AGE-RAGE signaling pathway in diabetic complications	1/1	135/7206	0.01873438801
ko04919	Thyroid hormone signaling pathway	1/1	143/7206	0.0198445739662
ko05160	Hepatitis C	1/1	153/7206	0.0212323064114
ko04621	NOD-like receptor signaling pathway	1/1	157/7206	0.0217873993895
ko05164	Influenza A	1/1	167/7206	0.0231751318347
ko05161	Hepatitis B	1/1	173/7206	0.0240077713018
ko04217	Necroptosis	1/1	178/7206	0.0247016375244
ko05168	Herpes simplex infection	1/1	182/7206	0.0252567305025
ko05152	Tuberculosis	1/1	187/7206	0.0259505967251
ko05167	Kaposi's sarcoma-associated herpesvirus infection	1/1	191/7206	0.0265056897032
ko04062	Chemokine signaling pathway	1/1	201/7206	0.0278934221483